These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies. Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605 [TBL] [Abstract][Full Text] [Related]
3. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis. Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis. Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861 [TBL] [Abstract][Full Text] [Related]
5. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis. Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522 [TBL] [Abstract][Full Text] [Related]
6. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria. Agrawal V; Prasad N; Jain M; Pandey R Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573 [TBL] [Abstract][Full Text] [Related]
7. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease. da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279 [TBL] [Abstract][Full Text] [Related]
8. Podocyte mRNA in the urinary sediment of minimal change nephropathy and focal segmental glomerulosclerosis. Szeto CC; Wang G; Chow KM; Lai FM; Ma TK; Kwan BC; Luk CC; Li PK Clin Nephrol; 2015 Oct; 84(4):198-205. PubMed ID: 26308082 [TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome. Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878 [TBL] [Abstract][Full Text] [Related]
10. Urinary podocytes in primary focal segmental glomerulosclerosis. Hara M; Yanagihara T; Kihara I Nephron; 2001 Nov; 89(3):342-7. PubMed ID: 11598401 [TBL] [Abstract][Full Text] [Related]
11. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis. Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022 [TBL] [Abstract][Full Text] [Related]
12. Rac1 activation in podocytes induces the spectrum of nephrotic syndrome. Robins R; Baldwin C; Aoudjit L; Côté JF; Gupta IR; Takano T Kidney Int; 2017 Aug; 92(2):349-364. PubMed ID: 28483380 [TBL] [Abstract][Full Text] [Related]
13. [The clinic significance of urinary podocytes in patients with focal segmental glomerulosclerosis]. Li YH; Huang HC; Liu G; Zhang YK Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):135-8. PubMed ID: 15100729 [TBL] [Abstract][Full Text] [Related]
14. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS? Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986 [TBL] [Abstract][Full Text] [Related]
15. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis. Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776 [TBL] [Abstract][Full Text] [Related]
16. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children. Srivastava T; Garola RE; Singh HK Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597 [TBL] [Abstract][Full Text] [Related]
17. Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Srivastava T; Garola RE; Whiting JM; Alon US Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064 [TBL] [Abstract][Full Text] [Related]
18. Decreased GM3 correlates with proteinuria in minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Naito S; Kawashima N; Ishii D; Fujita T; Iwamura M; Takeuchi Y Clin Exp Nephrol; 2022 Nov; 26(11):1078-1085. PubMed ID: 35804208 [TBL] [Abstract][Full Text] [Related]
19. Low birthweight and premature birth are risk factors for podocytopenia and focal segmental glomerulosclerosis. Ikezumi Y; Suzuki T; Karasawa T; Yamada T; Hasegawa H; Nishimura H; Uchiyama M Am J Nephrol; 2013; 38(2):149-57. PubMed ID: 23920104 [TBL] [Abstract][Full Text] [Related]
20. Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease. Smeets B; Stucker F; Wetzels J; Brocheriou I; Ronco P; Gröne HJ; D'Agati V; Fogo AB; van Kuppevelt TH; Fischer HP; Boor P; Floege J; Ostendorf T; Moeller MJ Am J Pathol; 2014 Dec; 184(12):3239-48. PubMed ID: 25307344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]